5-HTP Efficacy and Contraindications [Expression of Concern]
Hinz M, Stein A, Uncini T. Neuropsychiatr Dis Treat. 2012;8:323– 328. The Editor-in-Chief and Publisher of Neuropsychiatric Disease and Treatment wish to issue an Expression of Concern for the published article. Concerns have been raised regarding the alleged un...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b88ed92b98f747b4a0c08a10f8576cb5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b88ed92b98f747b4a0c08a10f8576cb5 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b88ed92b98f747b4a0c08a10f8576cb52021-12-02T11:48:14Z5-HTP Efficacy and Contraindications [Expression of Concern]1178-2021https://doaj.org/article/b88ed92b98f747b4a0c08a10f8576cb52020-04-01T00:00:00Zhttps://www.dovepress.com/eoc-5-htp-efficacy-and-contraindications-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Hinz M, Stein A, Uncini T. Neuropsychiatr Dis Treat. 2012;8:323– 328. The Editor-in-Chief and Publisher of Neuropsychiatric Disease and Treatment wish to issue an Expression of Concern for the published article. Concerns have been raised regarding the alleged undisclosed competing interests of some of the authors and alleged excessive self-citation for the published article. Neuropsychiatric Disease and Treatment would like to alert readers of this while our investigation is still ongoing and we will provide an update following the conclusion of our investigation. The authors have been informed of these concerns and of our investigation. Read the original articleHinz MStein AUncini TDove Medical Pressarticle5-htp5-hydroxytryptophanl-5-htpl-5-hydroxytryptophan.Neurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 16, Pp 1059-1060 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
5-htp 5-hydroxytryptophan l-5-htp l-5-hydroxytryptophan. Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
5-htp 5-hydroxytryptophan l-5-htp l-5-hydroxytryptophan. Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Hinz M Stein A Uncini T 5-HTP Efficacy and Contraindications [Expression of Concern] |
description |
Hinz M, Stein A, Uncini T. Neuropsychiatr Dis Treat. 2012;8:323– 328.
The Editor-in-Chief and Publisher of Neuropsychiatric Disease and Treatment wish to issue an Expression of Concern for the published article.
Concerns have been raised regarding the alleged undisclosed competing interests of some of the authors and alleged excessive self-citation for the published article. Neuropsychiatric Disease and Treatment would like to alert readers of this while our investigation is still ongoing and we will provide an update following the conclusion of our investigation.
The authors have been informed of these concerns and of our investigation.
Read the original article |
format |
article |
author |
Hinz M Stein A Uncini T |
author_facet |
Hinz M Stein A Uncini T |
author_sort |
Hinz M |
title |
5-HTP Efficacy and Contraindications [Expression of Concern] |
title_short |
5-HTP Efficacy and Contraindications [Expression of Concern] |
title_full |
5-HTP Efficacy and Contraindications [Expression of Concern] |
title_fullStr |
5-HTP Efficacy and Contraindications [Expression of Concern] |
title_full_unstemmed |
5-HTP Efficacy and Contraindications [Expression of Concern] |
title_sort |
5-htp efficacy and contraindications [expression of concern] |
publisher |
Dove Medical Press |
publishDate |
2020 |
url |
https://doaj.org/article/b88ed92b98f747b4a0c08a10f8576cb5 |
work_keys_str_mv |
AT hinzm 5htpefficacyandcontraindicationsexpressionofconcern AT steina 5htpefficacyandcontraindicationsexpressionofconcern AT uncinit 5htpefficacyandcontraindicationsexpressionofconcern |
_version_ |
1718395248344825856 |